WEST CHESTER, Pa., May 11, 2011 /PRNewswire/ — Animas
Corporation and LifeScan, Inc., both members of the Johnson &
Johnson Family of Diabetes Companies, today announced plans to
further build upon their existing collaborative efforts to
co-develop and market innovative new products and tools for people
living with diabetes. The increased collaboration also will
include more closely aligning their commercial organizations to
actively co-promote their product offerings, such as the
OneTouch® Ping® Glucose Management System. Animas and
LifeScan will work closely to bring people with diabetes and their
healthcare professionals the tools they need to better manage a
disease that affects more than 285 million people across the
globe.
Animas and LifeScan began their relationship with a joint
development project that started even before Johnson & Johnson
acquired Animas five years ago. The two companies joined forces to
co-develop the OneTouch® Ping® Glucose Management System,
the first full-feature insulin pump that wirelessly communicates
with a blood glucose meter-remote. The pump includes many unique
capabilities, and with the OneTouch® Ping® meter-remote, a
person can check blood glucose levels, calculate insulin doses, and
opt to wirelessly instruct the pump to deliver insulin without
touching the pump at all, giving patients more freedom and
flexibility.
“Our collective innovation and product pipeline is the strongest
it has been in a decade,” said Michel Paul, Company Group Chairman,
Johnson & Johnson Family of Diabetes Companies. “Through closer
alignment, we will unleash the power and strength of our two
companies and the overarching Johnson & Johnson Family of
Diabetes Companies. Together, we will work to advance care for
people with diabetes, as well as education and research for
families and healthcare professionals, to ultimately enable
diabetes patients to maintain better blood glucose c
‘/>”/>
